Biotechnology and Its Application

Biotechnological Applications in Agriculture: GM Crops

One of the most significant applications of biotechnology is in agriculture, primarily through the creation of Genetically Modified Organisms (GMOs), specifically Genetically Modified (GM) crops. Why do we need them? Traditional agriculture faces challenges from pests, weeds, and environmental stress, which limit crop yield. Biotechnology offers a way to make crops more resilient.

A prime example is Bt cotton. Scientists identified a gene in the bacterium Bacillus thuringiensis (Bt) that produces a protein toxic to certain insects, like bollworms. This gene, called the Cry gene, was isolated and introduced into the cotton plant's genome. Now, the cotton plant itself produces this insecticidal protein in an inactive form (protoxin). When a bollworm eats the plant, the alkaline pH of its gut activates the toxin. The activated toxin binds to the surface of the insect's midgut cells, creating pores that cause cell swelling and lysis, ultimately killing the pest. This reduces the need for chemical pesticides, making farming more sustainable and safer for the environment. Another powerful technique is RNA interference (RNAi), used to create nematode-resistant tobacco plants by silencing specific mRNA of the parasite.

Breakthroughs in Medicine: Insulin, Gene Therapy, and Diagnostics

Biotechnology has transformed medicine. A classic example is the production of human insulin. Previously, diabetics used insulin extracted from pigs and cattle, which could cause allergic reactions. Using recombinant DNA technology, scientists now produce 'humulin'. They introduce the human genes for the A and B polypeptide chains of insulin into E. coli plasmids. These bacteria then act as factories, producing the chains separately. The chains are extracted, purified, and joined by creating disulfide bonds to form functional human insulin, which is safe and effective for patients.

Gene therapy represents a more advanced application, aiming to correct genetic defects. The first clinical gene therapy was given in 1990 to a 4-year-old girl with adenosine deaminase (ADA) deficiency, a disorder that severely compromises the immune system. Lymphocytes were taken from her blood, and a functional ADA cDNA (using a retroviral vector) was introduced into them. These genetically engineered cells were then returned to the patient. While not a permanent cure, it's a major step towards treating genetic diseases.

Finally, biotechnology provides powerful diagnostic tools. PCR (Polymerase Chain Reaction) can amplify minute amounts of DNA, allowing for early detection of pathogens or genetic mutations. ELISA (Enzyme-Linked Immunosorbent Assay) detects the presence of antigens or antibodies, and is widely used for tests like HIV detection.

Process: Creating Genetically Engineered Insulin (Humulin)

1. Step 1: Gene Isolation and Plasmid Preparation — The two genes that code for the A and B polypeptide chains of human insulin are chemically synthesized or isolated from human pancreatic cells. Simultaneously, plasmids are extracted from the bacterium E. coli and cut with a specific restriction enzyme.
2. Step 2: Creating Recombinant DNA — The gene for chain A is inserted into one batch of plasmids, and the gene for chain B is inserted into another batch. The enzyme DNA ligase is used to join the genes to the plasmids, creating two types of recombinant DNA molecules.
3. Step 3: Transformation — The recombinant plasmids are introduced back into E. coli host cells. The bacteria that successfully take up the plasmids are now considered 'transformed' or genetically modified.
4. Step 4: Culturing and Protein Production — The transformed bacteria are grown in large fermentation tanks (bioreactors). Under optimal conditions, they multiply rapidly and, as they express their genes, produce large quantities of either chain A or chain B.
5. Step 5: Extraction and Assembly — The polypeptide chains (A and B) are extracted from the bacteria and purified. Finally, the two chains are chemically joined by creating disulfide bonds between them to form a mature, fully functional human insulin molecule (Humulin).

Exam Tip: Ethical Issues and the Role of GEAC

A very important topic for board exams is the ethical dimension of biotechnology. While GMOs offer benefits, they also raise concerns. For example, will introducing a modified organism into an ecosystem have unpredictable and harmful consequences? What about the morality of tampering with the genetic makeup of living beings? Another issue is biopiracy: the commercial exploitation of bio-resources by organizations and nations without proper authorization or compensation to the source communities.

To address these concerns, the Indian Government has set up the Genetic Engineering Appraisal Committee (GEAC). Remember this name! GEAC's primary role is to evaluate the validity of GM research and ensure the safety of introducing GMOs for public services. Any decision to mass-produce or release a GM product must be approved by GEAC. Questions on the role of GEAC and ethical issues are common in both short answer and long answer formats.

Practice Questions with Solutions

• Q: Explain the mechanism of RNA interference (RNAi) and how it was used to develop a nematode-resistant tobacco plant. A: Step 1: RNA interference (RNAi) is a natural cellular defense mechanism in all eukaryotic organisms. It involves silencing a specific mRNA molecule, preventing its translation into a protein. This is achieved using a complementary double-stranded RNA (dsRNA) molecule that binds to and targets the specific mRNA for degradation. Step 2: To create nematode-resistant tobacco, scientists used the Agrobacterium vector to introduce nematode-specific genes into the host plant. The introduced DNA was designed to produce both sense and anti-sense RNA in the host cells. Step 3: These two RNAs, being complementary, formed a double-stranded RNA (dsRNA). This initiated the RNAi process in the tobacco plant cells. Step 4: When the nematode Meloidegyne incognita infects the plant and ingests these cells, the dsRNA is introduced into its body. This triggers RNAi in the nematode, silencing the specific mRNA crucial for its survival. Final answer: As a result, the parasite cannot produce a vital protein, it dies, and the transgenic tobacco plant is protected from infection.
• Q: Why is the insulin produced by genetically engineered E. coli considered superior to the insulin previously extracted from slaughtered cattle and pigs? A: Step 1: The primary issue with insulin from non-human sources (like cattle and pigs) was its potential to cause immune responses in humans. Although structurally similar, it is not identical to human insulin and the body could recognize it as a foreign substance, leading to allergies or other complications. Step 2: Genetically engineered insulin, or 'humulin', is produced using the actual human insulin gene. This means the resulting protein is structurally identical to the insulin produced by the human pancreas. Step 3: Because it is identical, the risk of an allergic or immune reaction is virtually eliminated, making it much safer for long-term use by diabetic patients. Final answer: Therefore, genetically engineered insulin is superior because it is human-identical, avoiding the immunological problems associated with animal-derived insulin.
• Q: What is gene therapy? Describe the steps involved in the gene therapy for Adenosine Deaminase (ADA) deficiency. A: Step 1: Gene therapy is a collection of methods that allows the correction of a gene defect that has been diagnosed in a child or embryo. It involves delivering a normal, functional gene into an individual's cells to compensate for a non-functional or missing gene. Step 2: In the case of ADA deficiency, the first step is to extract lymphocytes (a type of white blood cell) from the patient's bone marrow or blood. Step 3: A functional ADA gene (as cDNA) is then introduced into these lymphocytes using a retrovirus as a vector. The retrovirus inserts the gene into the cell's genome. Step 4: The genetically modified lymphocytes are then grown in a culture to increase their numbers. Step 5: Finally, these corrected lymphocytes are infused back into the patient's bloodstream. Final answer: The patient receives periodic infusions of these genetically engineered cells to maintain a functional immune system. However, since lymphocytes are not immortal, this is not a permanent cure. A permanent cure would require introducing the gene into stem cells at an early embryonic stage.
• Q: Define biopiracy. Why is it an ethical concern and what body in India addresses such issues? A: Step 1: Biopiracy is defined as the practice of commercially exploiting naturally occurring biochemical or genetic material, especially by obtaining patents that restrict its future use, without providing fair compensation to the communities or countries from which it originates. Step 2: It is a major ethical concern because it represents the theft of traditional knowledge and biological resources from indigenous people and developing nations. It allows large corporations to profit from resources and knowledge that have been cultivated and understood for generations, without sharing the benefits. Step 3: In India, the body set up to deal with such issues, including the validity of GM research and the safety of GMOs, is the Genetic Engineering Appraisal Committee (GEAC). GEAC makes decisions regarding the release of genetically modified organisms and products into the environment and for public use. Final answer: Biopiracy is the unethical patenting and commercialization of bioresources without proper authorization or benefit sharing, and it is regulated in India by bodies like the GEAC.

Frequently Asked Questions